Hancock Whitney’s Exact Sciences EXAS Stock Holding History

Hancock Whitney’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,552	Closed	-$248K	–	645
2022 Q1	$248K	Buy	+3,552	New	+$260K	0.01%	622

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Hancock Whitney's EXAS Position: Q2 2022 in Review

Hancock Whitney sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 3,552 shares — an estimated $248K sold.

Hancock Whitney first reported a position in EXAS in Q1 2022 and held it in 1 quarter. The position peaked at $248K in Q1 2022. 500 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

Hancock Whitney reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
Hancock Whitney sold 3,552 Exact Sciences shares in Q2 2022, an estimated $248K.
Hancock Whitney first reported a position in Exact Sciences in Q1 2022 and held it in 1 quarter.
Hancock Whitney's Exact Sciences position peaked at $248K in Q1 2022.
500 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Hancock Whitney's 13F filing for Q2 2022, filed 8 Aug 2022.